The Cigna Group CI
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 73.40B | 71.40B | 68.29B | 72.13B | 69.52B |
| Total Other Revenue | 287.00M | 272.00M | 202.00M | 339.00M | 233.00M |
| Total Revenue | 73.68B | 71.67B | 68.49B | 72.47B | 69.75B |
| Cost of Revenue | 67.09B | 65.13B | 62.02B | 66.06B | 63.37B |
| Gross Profit | 6.60B | 6.54B | 6.47B | 6.42B | 6.38B |
| SG&A Expenses | 3.44B | 3.29B | 2.33B | 3.30B | 3.19B |
| Depreciation & Amortization | 589.00M | 389.00M | 390.00M | 463.00M | 436.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.12B | 68.81B | 64.74B | 69.82B | 67.00B |
| Operating Income | 2.57B | 2.86B | 3.75B | 2.66B | 2.75B |
| Income Before Tax | 2.10B | 2.26B | 2.27B | 1.82B | 2.30B |
| Income Tax Expenses | 401.00M | 382.00M | 409.00M | 543.00M | 322.00M |
| Earnings from Continuing Operations | 1.70B | 1.88B | 1.86B | 1.27B | 1.97B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -256.00M | -215.00M | -207.00M | -40.00M | -105.00M |
| Net Income | 1.44B | 1.66B | 1.65B | 1.23B | 1.87B |
| EBIT | 2.57B | 2.86B | 3.75B | 2.66B | 2.75B |
| EBITDA | 3.43B | 3.51B | 4.40B | 3.38B | 3.45B |
| EPS Basic | 5.49 | 6.31 | 6.30 | 4.67 | 7.02 |
| Normalized Basic EPS | 4.33 | 5.12 | 7.29 | 5.28 | 5.25 |
| EPS Diluted | 5.47 | 6.29 | 6.26 | 4.65 | 6.98 |
| Normalized Diluted EPS | 4.32 | 5.10 | 7.25 | 5.25 | 5.22 |
| Average Basic Shares Outstanding | 262.79M | 262.99M | 262.75M | 264.07M | 265.91M |
| Average Diluted Shares Outstanding | 263.79M | 263.96M | 264.02M | 265.67M | 267.53M |
| Dividend Per Share | 1.56 | 1.56 | 1.56 | 1.51 | 1.51 |
| Payout Ratio | 28.43% | 24.64% | 25.21% | 32.09% | 21.52% |